Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • FCEL vs GSK✓SelectedUSD · GSKFCEL vs GSK performance historyLatest closeAs of-5.56%11/13
Stock and ETF performance explorer

FCEL vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-37.5%
GSK return
+8.1%
Excess return
-45.6%
Maximum drawdown
-42.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1mo.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-5.6%+0.5%-6.1%-5.1%
7D-2.8%+1.1%-4.0%-2.1%
30D-31.6%+6.3%-38.0%-27.7%
All-37.5%+8.1%-45.6%-31.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1mo: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1mo analysis · Full analysis span regression · Available span rolling